Nicholas Company, Inc. Bristol Myers Squibb CO Transaction History

Nicholas Company, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $30.9 Million - $36.1 Million	-576,840 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $9,763 - $11,436	-165 Reduced 0.03%	576,840 $34.1 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $2.5 Million - $2.72 Million	40,340 Added 7.52%	577,005 $38.6 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $1.45 Million - $1.64 Million	25,085 Added 4.9%	536,665 $33.3 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $2.3 Million - $2.55 Million	40,045 Added 8.49%	511,580 $30.8 Million

Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $11 Million - $12.9 Million	200,685 Added 74.09%	471,535 $27.7 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $928 - $1,348	-20 Reduced 0.01%	270,850 $15.1 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $13.3 Million - $17.4 Million	270,870 New	270,870 $17.4 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $13,386 - $14,802	-300 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $2.18 Million - $2.83 Million	-44,810 Reduced 99.33%	300 $15,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $2.49 Million - $2.81 Million	45,110 New	45,110 $2.8 Million

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85.2B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Nicholas Company, Inc. with notifications on news.